nodes	percent_of_prediction	percent_of_DWPC	metapath
Baclofen—Memory loss—Fluorouracil—head and neck cancer	0.0266	0.0277	CcSEcCtD
Baclofen—Ibuprofen—BCL2—head and neck cancer	0.0231	0.569	CrCbGaD
Baclofen—Slurred speech—Fluorouracil—head and neck cancer	0.0175	0.0182	CcSEcCtD
Baclofen—Cerebrovascular disorder—Fluorouracil—head and neck cancer	0.0175	0.0182	CcSEcCtD
Baclofen—Ileus—Vinblastine—head and neck cancer	0.0168	0.0175	CcSEcCtD
Baclofen—Nystagmus—Vinblastine—head and neck cancer	0.0167	0.0174	CcSEcCtD
Baclofen—Digestion impaired—Hydroxyurea—head and neck cancer	0.0162	0.0169	CcSEcCtD
Baclofen—Numbness—Vinblastine—head and neck cancer	0.0144	0.015	CcSEcCtD
Baclofen—Skin ulcer—Hydroxyurea—head and neck cancer	0.0139	0.0145	CcSEcCtD
Baclofen—Sensory loss—Vinblastine—head and neck cancer	0.0137	0.0143	CcSEcCtD
Baclofen—Chlorphenesin—PTGS2—head and neck cancer	0.0121	0.298	CrCbGaD
Baclofen—Chest tightness—Docetaxel—head and neck cancer	0.012	0.0125	CcSEcCtD
Baclofen—Photophobia—Vinblastine—head and neck cancer	0.0112	0.0116	CcSEcCtD
Baclofen—Nystagmus—Fluorouracil—head and neck cancer	0.0109	0.0114	CcSEcCtD
Baclofen—Tingling sensation—Fluorouracil—head and neck cancer	0.00972	0.0101	CcSEcCtD
Baclofen—Numbness—Fluorouracil—head and neck cancer	0.00942	0.00982	CcSEcCtD
Baclofen—Deep vein thrombosis—Docetaxel—head and neck cancer	0.00927	0.00966	CcSEcCtD
Baclofen—Speech disorder—Fluorouracil—head and neck cancer	0.00908	0.00946	CcSEcCtD
Baclofen—Sensory loss—Fluorouracil—head and neck cancer	0.00902	0.0094	CcSEcCtD
Baclofen—Cerebrovascular accident—Vinblastine—head and neck cancer	0.00881	0.00919	CcSEcCtD
Baclofen—Disorientation—Hydroxyurea—head and neck cancer	0.00881	0.00918	CcSEcCtD
Baclofen—Leukocytosis—Fluorouracil—head and neck cancer	0.00831	0.00866	CcSEcCtD
Baclofen—Dysarthria—Fluorouracil—head and neck cancer	0.00826	0.00861	CcSEcCtD
Baclofen—Ileus—Docetaxel—head and neck cancer	0.00796	0.0083	CcSEcCtD
Baclofen—Dermatitis contact—Fluorouracil—head and neck cancer	0.00772	0.00805	CcSEcCtD
Baclofen—Face oedema—Hydroxyurea—head and neck cancer	0.0076	0.00793	CcSEcCtD
Baclofen—Photophobia—Fluorouracil—head and neck cancer	0.00733	0.00764	CcSEcCtD
Baclofen—Coma—Fluorouracil—head and neck cancer	0.00714	0.00744	CcSEcCtD
Baclofen—Breast disorder—Hydroxyurea—head and neck cancer	0.00712	0.00742	CcSEcCtD
Baclofen—Ageusia—Docetaxel—head and neck cancer	0.00696	0.00725	CcSEcCtD
Baclofen—Sepsis—Fluorouracil—head and neck cancer	0.00678	0.00706	CcSEcCtD
Baclofen—Euphoric mood—Fluorouracil—head and neck cancer	0.00671	0.00699	CcSEcCtD
Baclofen—Depression—Vinblastine—head and neck cancer	0.00664	0.00692	CcSEcCtD
Baclofen—Thrombophlebitis—Fluorouracil—head and neck cancer	0.00655	0.00683	CcSEcCtD
Baclofen—Swelling—Fluorouracil—head and neck cancer	0.00643	0.0067	CcSEcCtD
Baclofen—Chest discomfort—Docetaxel—head and neck cancer	0.00637	0.00664	CcSEcCtD
Baclofen—Dysuria—Hydroxyurea—head and neck cancer	0.00637	0.00664	CcSEcCtD
Baclofen—Disorientation—Fluorouracil—head and neck cancer	0.00634	0.00661	CcSEcCtD
Baclofen—Weight increased—Hydroxyurea—head and neck cancer	0.0062	0.00646	CcSEcCtD
Baclofen—Oliguria—Docetaxel—head and neck cancer	0.00612	0.00638	CcSEcCtD
Baclofen—Drowsiness—Hydroxyurea—head and neck cancer	0.00607	0.00633	CcSEcCtD
Baclofen—Amnesia—Fluorouracil—head and neck cancer	0.00603	0.00629	CcSEcCtD
Baclofen—Hypoaesthesia—Vinblastine—head and neck cancer	0.00595	0.0062	CcSEcCtD
Baclofen—Lethargy—Fluorouracil—head and neck cancer	0.00579	0.00603	CcSEcCtD
Baclofen—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.00574	0.00598	CcSEcCtD
Baclofen—Respiratory failure—Docetaxel—head and neck cancer	0.00574	0.00598	CcSEcCtD
Baclofen—Osteoarthritis—Fluorouracil—head and neck cancer	0.00567	0.00591	CcSEcCtD
Baclofen—Gastrointestinal haemorrhage—Fluorouracil—head and neck cancer	0.00567	0.00591	CcSEcCtD
Baclofen—Phosphatase alkaline increased—Docetaxel—head and neck cancer	0.00564	0.00588	CcSEcCtD
Baclofen—Pulmonary embolism—Docetaxel—head and neck cancer	0.00564	0.00588	CcSEcCtD
Baclofen—Hallucination—Hydroxyurea—head and neck cancer	0.00542	0.00565	CcSEcCtD
Baclofen—Ibuprofen—PTGS2—head and neck cancer	0.0054	0.133	CrCbGaD
Baclofen—Ataxia—Fluorouracil—head and neck cancer	0.00533	0.00556	CcSEcCtD
Baclofen—Alopecia—Vinblastine—head and neck cancer	0.00528	0.0055	CcSEcCtD
Baclofen—Lightheadedness—Docetaxel—head and neck cancer	0.00504	0.00526	CcSEcCtD
Baclofen—Muscular weakness—Fluorouracil—head and neck cancer	0.005	0.00521	CcSEcCtD
Baclofen—Angiopathy—Hydroxyurea—head and neck cancer	0.00494	0.00515	CcSEcCtD
Baclofen—Dysphagia—Fluorouracil—head and neck cancer	0.0049	0.00511	CcSEcCtD
Baclofen—Sepsis—Docetaxel—head and neck cancer	0.00489	0.0051	CcSEcCtD
Baclofen—Chills—Hydroxyurea—head and neck cancer	0.00489	0.0051	CcSEcCtD
Baclofen—Ill-defined disorder—Vinblastine—head and neck cancer	0.00483	0.00503	CcSEcCtD
Baclofen—Alopecia—Hydroxyurea—head and neck cancer	0.00482	0.00502	CcSEcCtD
Baclofen—Anaemia—Vinblastine—head and neck cancer	0.00481	0.00501	CcSEcCtD
Baclofen—Thrombophlebitis—Docetaxel—head and neck cancer	0.00473	0.00493	CcSEcCtD
Baclofen—Blood alkaline phosphatase increased—Docetaxel—head and neck cancer	0.0047	0.0049	CcSEcCtD
Baclofen—Malaise—Vinblastine—head and neck cancer	0.00469	0.00489	CcSEcCtD
Baclofen—Vertigo—Vinblastine—head and neck cancer	0.00467	0.00487	CcSEcCtD
Baclofen—Swelling—Docetaxel—head and neck cancer	0.00464	0.00483	CcSEcCtD
Baclofen—Convulsion—Vinblastine—head and neck cancer	0.00451	0.0047	CcSEcCtD
Baclofen—Hypertension—Vinblastine—head and neck cancer	0.00449	0.00468	CcSEcCtD
Baclofen—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.0044	0.00459	CcSEcCtD
Baclofen—Pneumonia—Fluorouracil—head and neck cancer	0.00439	0.00458	CcSEcCtD
Baclofen—Anaemia—Hydroxyurea—head and neck cancer	0.00438	0.00457	CcSEcCtD
Baclofen—Discomfort—Vinblastine—head and neck cancer	0.00438	0.00456	CcSEcCtD
Baclofen—Visual disturbance—Docetaxel—head and neck cancer	0.00432	0.0045	CcSEcCtD
Baclofen—Malaise—Hydroxyurea—head and neck cancer	0.00428	0.00446	CcSEcCtD
Baclofen—Lethargy—Docetaxel—head and neck cancer	0.00418	0.00435	CcSEcCtD
Baclofen—Convulsion—Hydroxyurea—head and neck cancer	0.00411	0.00428	CcSEcCtD
Baclofen—Gastrointestinal haemorrhage—Docetaxel—head and neck cancer	0.00409	0.00427	CcSEcCtD
Baclofen—Anorexia—Vinblastine—head and neck cancer	0.00405	0.00422	CcSEcCtD
Baclofen—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00401	0.00418	CcSEcCtD
Baclofen—Discomfort—Hydroxyurea—head and neck cancer	0.00399	0.00416	CcSEcCtD
Baclofen—Rhinitis—Fluorouracil—head and neck cancer	0.00393	0.0041	CcSEcCtD
Baclofen—Hypoaesthesia—Fluorouracil—head and neck cancer	0.0039	0.00407	CcSEcCtD
Baclofen—Oedema—Hydroxyurea—head and neck cancer	0.00387	0.00404	CcSEcCtD
Baclofen—Ataxia—Docetaxel—head and neck cancer	0.00385	0.00401	CcSEcCtD
Baclofen—Infection—Hydroxyurea—head and neck cancer	0.00385	0.00401	CcSEcCtD
Baclofen—Paraesthesia—Vinblastine—head and neck cancer	0.00381	0.00397	CcSEcCtD
Baclofen—Dehydration—Docetaxel—head and neck cancer	0.00381	0.00397	CcSEcCtD
Baclofen—Nervous system disorder—Hydroxyurea—head and neck cancer	0.0038	0.00396	CcSEcCtD
Baclofen—Skin disorder—Hydroxyurea—head and neck cancer	0.00376	0.00392	CcSEcCtD
Baclofen—Orthostatic hypotension—Docetaxel—head and neck cancer	0.00374	0.0039	CcSEcCtD
Baclofen—Breast disorder—Docetaxel—head and neck cancer	0.0037	0.00385	CcSEcCtD
Baclofen—Anorexia—Hydroxyurea—head and neck cancer	0.00369	0.00385	CcSEcCtD
Baclofen—Decreased appetite—Vinblastine—head and neck cancer	0.00369	0.00385	CcSEcCtD
Baclofen—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	0.00368	0.00384	CcSEcCtD
Baclofen—Pain—Vinblastine—head and neck cancer	0.00363	0.00378	CcSEcCtD
Baclofen—Constipation—Vinblastine—head and neck cancer	0.00363	0.00378	CcSEcCtD
Baclofen—Dysphagia—Docetaxel—head and neck cancer	0.00354	0.00369	CcSEcCtD
Baclofen—Arrhythmia—Fluorouracil—head and neck cancer	0.0035	0.00365	CcSEcCtD
Baclofen—Feeling abnormal—Vinblastine—head and neck cancer	0.0035	0.00365	CcSEcCtD
Baclofen—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00347	0.00362	CcSEcCtD
Baclofen—Alopecia—Fluorouracil—head and neck cancer	0.00347	0.00361	CcSEcCtD
Baclofen—Dyspnoea—Hydroxyurea—head and neck cancer	0.00345	0.0036	CcSEcCtD
Baclofen—Somnolence—Hydroxyurea—head and neck cancer	0.00344	0.00359	CcSEcCtD
Baclofen—Dyspepsia—Hydroxyurea—head and neck cancer	0.00341	0.00355	CcSEcCtD
Baclofen—Decreased appetite—Hydroxyurea—head and neck cancer	0.00337	0.00351	CcSEcCtD
Baclofen—Abdominal pain—Vinblastine—head and neck cancer	0.00336	0.0035	CcSEcCtD
Baclofen—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00334	0.00348	CcSEcCtD
Baclofen—Fatigue—Hydroxyurea—head and neck cancer	0.00334	0.00348	CcSEcCtD
Baclofen—Pain—Hydroxyurea—head and neck cancer	0.00331	0.00345	CcSEcCtD
Baclofen—Constipation—Hydroxyurea—head and neck cancer	0.00331	0.00345	CcSEcCtD
Baclofen—Weight increased—Docetaxel—head and neck cancer	0.00322	0.00335	CcSEcCtD
Baclofen—Vision blurred—Fluorouracil—head and neck cancer	0.00322	0.00335	CcSEcCtD
Baclofen—Weight decreased—Docetaxel—head and neck cancer	0.0032	0.00334	CcSEcCtD
Baclofen—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00319	0.00333	CcSEcCtD
Baclofen—Pneumonia—Docetaxel—head and neck cancer	0.00317	0.00331	CcSEcCtD
Baclofen—Anaemia—Fluorouracil—head and neck cancer	0.00316	0.00329	CcSEcCtD
Baclofen—Renal failure—Docetaxel—head and neck cancer	0.0031	0.00323	CcSEcCtD
Baclofen—Body temperature increased—Hydroxyurea—head and neck cancer	0.00306	0.00319	CcSEcCtD
Baclofen—Asthenia—Vinblastine—head and neck cancer	0.00305	0.00317	CcSEcCtD
Baclofen—Hepatobiliary disease—Docetaxel—head and neck cancer	0.00298	0.00311	CcSEcCtD
Baclofen—Convulsion—Fluorouracil—head and neck cancer	0.00296	0.00308	CcSEcCtD
Baclofen—Myalgia—Fluorouracil—head and neck cancer	0.00291	0.00303	CcSEcCtD
Baclofen—Chest pain—Fluorouracil—head and neck cancer	0.00291	0.00303	CcSEcCtD
Baclofen—Diarrhoea—Vinblastine—head and neck cancer	0.0029	0.00303	CcSEcCtD
Baclofen—Discomfort—Fluorouracil—head and neck cancer	0.00287	0.00299	CcSEcCtD
Baclofen—Rhinitis—Docetaxel—head and neck cancer	0.00284	0.00296	CcSEcCtD
Baclofen—Hypoaesthesia—Docetaxel—head and neck cancer	0.00282	0.00294	CcSEcCtD
Baclofen—Confusional state—Fluorouracil—head and neck cancer	0.00281	0.00293	CcSEcCtD
Baclofen—Dizziness—Vinblastine—head and neck cancer	0.00281	0.00293	CcSEcCtD
Baclofen—Urinary tract disorder—Docetaxel—head and neck cancer	0.0028	0.00291	CcSEcCtD
Baclofen—Oedema peripheral—Docetaxel—head and neck cancer	0.00279	0.00291	CcSEcCtD
Baclofen—Oedema—Fluorouracil—head and neck cancer	0.00279	0.0029	CcSEcCtD
Baclofen—Connective tissue disorder—Docetaxel—head and neck cancer	0.00278	0.0029	CcSEcCtD
Baclofen—Asthenia—Hydroxyurea—head and neck cancer	0.00278	0.0029	CcSEcCtD
Baclofen—Urethral disorder—Docetaxel—head and neck cancer	0.00278	0.00289	CcSEcCtD
Baclofen—Infection—Fluorouracil—head and neck cancer	0.00277	0.00289	CcSEcCtD
Baclofen—Nervous system disorder—Fluorouracil—head and neck cancer	0.00273	0.00285	CcSEcCtD
Baclofen—Visual impairment—Docetaxel—head and neck cancer	0.00273	0.00284	CcSEcCtD
Baclofen—Tachycardia—Fluorouracil—head and neck cancer	0.00272	0.00283	CcSEcCtD
Baclofen—Vomiting—Vinblastine—head and neck cancer	0.0027	0.00281	CcSEcCtD
Baclofen—Headache—Vinblastine—head and neck cancer	0.00266	0.00277	CcSEcCtD
Baclofen—Anorexia—Fluorouracil—head and neck cancer	0.00266	0.00277	CcSEcCtD
Baclofen—Diarrhoea—Hydroxyurea—head and neck cancer	0.00265	0.00276	CcSEcCtD
Baclofen—Eye disorder—Docetaxel—head and neck cancer	0.00265	0.00276	CcSEcCtD
Baclofen—Cardiac disorder—Docetaxel—head and neck cancer	0.00263	0.00274	CcSEcCtD
Baclofen—Flushing—Docetaxel—head and neck cancer	0.00263	0.00274	CcSEcCtD
Baclofen—Hypotension—Fluorouracil—head and neck cancer	0.0026	0.00271	CcSEcCtD
Baclofen—Angiopathy—Docetaxel—head and neck cancer	0.00257	0.00268	CcSEcCtD
Baclofen—Dizziness—Hydroxyurea—head and neck cancer	0.00256	0.00267	CcSEcCtD
Baclofen—Mediastinal disorder—Docetaxel—head and neck cancer	0.00255	0.00266	CcSEcCtD
Baclofen—Chills—Docetaxel—head and neck cancer	0.00254	0.00265	CcSEcCtD
Baclofen—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.00254	0.00265	CcSEcCtD
Baclofen—Arrhythmia—Docetaxel—head and neck cancer	0.00253	0.00264	CcSEcCtD
Baclofen—Nausea—Vinblastine—head and neck cancer	0.00252	0.00263	CcSEcCtD
Baclofen—Insomnia—Fluorouracil—head and neck cancer	0.00252	0.00263	CcSEcCtD
Baclofen—Paraesthesia—Fluorouracil—head and neck cancer	0.0025	0.00261	CcSEcCtD
Baclofen—Alopecia—Docetaxel—head and neck cancer	0.0025	0.00261	CcSEcCtD
Baclofen—Dyspnoea—Fluorouracil—head and neck cancer	0.00248	0.00259	CcSEcCtD
Baclofen—Mental disorder—Docetaxel—head and neck cancer	0.00248	0.00259	CcSEcCtD
Baclofen—Somnolence—Fluorouracil—head and neck cancer	0.00248	0.00258	CcSEcCtD
Baclofen—Malnutrition—Docetaxel—head and neck cancer	0.00246	0.00257	CcSEcCtD
Baclofen—Vomiting—Hydroxyurea—head and neck cancer	0.00246	0.00257	CcSEcCtD
Baclofen—Dyspepsia—Fluorouracil—head and neck cancer	0.00245	0.00256	CcSEcCtD
Baclofen—Rash—Hydroxyurea—head and neck cancer	0.00244	0.00254	CcSEcCtD
Baclofen—Dermatitis—Hydroxyurea—head and neck cancer	0.00244	0.00254	CcSEcCtD
Baclofen—Headache—Hydroxyurea—head and neck cancer	0.00243	0.00253	CcSEcCtD
Baclofen—Decreased appetite—Fluorouracil—head and neck cancer	0.00242	0.00252	CcSEcCtD
Baclofen—Dysgeusia—Docetaxel—head and neck cancer	0.00241	0.00252	CcSEcCtD
Baclofen—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00241	0.00251	CcSEcCtD
Baclofen—Back pain—Docetaxel—head and neck cancer	0.00238	0.00248	CcSEcCtD
Baclofen—Pain—Fluorouracil—head and neck cancer	0.00238	0.00248	CcSEcCtD
Baclofen—Nausea—Hydroxyurea—head and neck cancer	0.0023	0.0024	CcSEcCtD
Baclofen—Feeling abnormal—Fluorouracil—head and neck cancer	0.0023	0.00239	CcSEcCtD
Baclofen—Anaemia—Docetaxel—head and neck cancer	0.00228	0.00237	CcSEcCtD
Baclofen—Urticaria—Fluorouracil—head and neck cancer	0.00221	0.00231	CcSEcCtD
Baclofen—Syncope—Docetaxel—head and neck cancer	0.00221	0.0023	CcSEcCtD
Baclofen—Body temperature increased—Fluorouracil—head and neck cancer	0.0022	0.0023	CcSEcCtD
Baclofen—Palpitations—Docetaxel—head and neck cancer	0.00218	0.00227	CcSEcCtD
Baclofen—Loss of consciousness—Docetaxel—head and neck cancer	0.00217	0.00226	CcSEcCtD
Baclofen—Convulsion—Docetaxel—head and neck cancer	0.00214	0.00223	CcSEcCtD
Baclofen—Hypertension—Docetaxel—head and neck cancer	0.00213	0.00222	CcSEcCtD
Baclofen—Myalgia—Docetaxel—head and neck cancer	0.0021	0.00219	CcSEcCtD
Baclofen—Chest pain—Docetaxel—head and neck cancer	0.0021	0.00219	CcSEcCtD
Baclofen—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.00208	0.00217	CcSEcCtD
Baclofen—Dry mouth—Docetaxel—head and neck cancer	0.00205	0.00214	CcSEcCtD
Baclofen—Confusional state—Docetaxel—head and neck cancer	0.00203	0.00211	CcSEcCtD
Baclofen—Oedema—Docetaxel—head and neck cancer	0.00201	0.0021	CcSEcCtD
Baclofen—Infection—Docetaxel—head and neck cancer	0.002	0.00208	CcSEcCtD
Baclofen—Shock—Docetaxel—head and neck cancer	0.00198	0.00206	CcSEcCtD
Baclofen—Nervous system disorder—Docetaxel—head and neck cancer	0.00197	0.00206	CcSEcCtD
Baclofen—Pruritus—Fluorouracil—head and neck cancer	0.00197	0.00205	CcSEcCtD
Baclofen—Tachycardia—Docetaxel—head and neck cancer	0.00196	0.00205	CcSEcCtD
Baclofen—Skin disorder—Docetaxel—head and neck cancer	0.00195	0.00204	CcSEcCtD
Baclofen—Anorexia—Docetaxel—head and neck cancer	0.00192	0.002	CcSEcCtD
Baclofen—Diarrhoea—Fluorouracil—head and neck cancer	0.00191	0.00199	CcSEcCtD
Baclofen—Hypotension—Docetaxel—head and neck cancer	0.00188	0.00196	CcSEcCtD
Baclofen—Dizziness—Fluorouracil—head and neck cancer	0.00184	0.00192	CcSEcCtD
Baclofen—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.00183	0.00191	CcSEcCtD
Baclofen—Insomnia—Docetaxel—head and neck cancer	0.00182	0.0019	CcSEcCtD
Baclofen—Paraesthesia—Docetaxel—head and neck cancer	0.00181	0.00188	CcSEcCtD
Baclofen—Dyspnoea—Docetaxel—head and neck cancer	0.00179	0.00187	CcSEcCtD
Baclofen—Somnolence—Docetaxel—head and neck cancer	0.00179	0.00186	CcSEcCtD
Baclofen—Vomiting—Fluorouracil—head and neck cancer	0.00177	0.00185	CcSEcCtD
Baclofen—Dyspepsia—Docetaxel—head and neck cancer	0.00177	0.00185	CcSEcCtD
Baclofen—Rash—Fluorouracil—head and neck cancer	0.00176	0.00183	CcSEcCtD
Baclofen—Dermatitis—Fluorouracil—head and neck cancer	0.00176	0.00183	CcSEcCtD
Baclofen—Decreased appetite—Docetaxel—head and neck cancer	0.00175	0.00182	CcSEcCtD
Baclofen—Headache—Fluorouracil—head and neck cancer	0.00175	0.00182	CcSEcCtD
Baclofen—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.00174	0.00181	CcSEcCtD
Baclofen—Fatigue—Docetaxel—head and neck cancer	0.00173	0.00181	CcSEcCtD
Baclofen—Pain—Docetaxel—head and neck cancer	0.00172	0.00179	CcSEcCtD
Baclofen—Constipation—Docetaxel—head and neck cancer	0.00172	0.00179	CcSEcCtD
Baclofen—Feeling abnormal—Docetaxel—head and neck cancer	0.00166	0.00173	CcSEcCtD
Baclofen—Nausea—Fluorouracil—head and neck cancer	0.00166	0.00173	CcSEcCtD
Baclofen—Gastrointestinal pain—Docetaxel—head and neck cancer	0.00164	0.00171	CcSEcCtD
Baclofen—Body temperature increased—Docetaxel—head and neck cancer	0.00159	0.00166	CcSEcCtD
Baclofen—Abdominal pain—Docetaxel—head and neck cancer	0.00159	0.00166	CcSEcCtD
Baclofen—Asthenia—Docetaxel—head and neck cancer	0.00144	0.0015	CcSEcCtD
Baclofen—Pruritus—Docetaxel—head and neck cancer	0.00142	0.00148	CcSEcCtD
Baclofen—Diarrhoea—Docetaxel—head and neck cancer	0.00138	0.00143	CcSEcCtD
Baclofen—Dizziness—Docetaxel—head and neck cancer	0.00133	0.00139	CcSEcCtD
Baclofen—Vomiting—Docetaxel—head and neck cancer	0.00128	0.00133	CcSEcCtD
Baclofen—Rash—Docetaxel—head and neck cancer	0.00127	0.00132	CcSEcCtD
Baclofen—Dermatitis—Docetaxel—head and neck cancer	0.00127	0.00132	CcSEcCtD
Baclofen—Headache—Docetaxel—head and neck cancer	0.00126	0.00131	CcSEcCtD
Baclofen—Nausea—Docetaxel—head and neck cancer	0.00119	0.00125	CcSEcCtD
